UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported): August
2, 2006
NovaMed,
Inc.
(Exact
Name of Registrant as Specified in Charter)
| |
|
|
|
Delaware
(State
or Other Jurisdiction
of
incorporation)
|
0-26625
(Commission
File
Number)
|
36-4116193
(IRS
Employer
Identification
No.)
|
| |
|
|
|
980
North Michigan Avenue, Suite 1620,
Chicago, Illinois
(Address
of Principal Executive
Offices)
|
60611
(Zip
Code)
|
| |
|
|
Registrant’s
telephone number, including area
code (312)
664-4100
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o Written
communications pursuant to Rule 425 under the Securities Act
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
Section
2 - Financial Information
Item
2.02 Results of Operations and Financial Condition.
On
August
2, 2006, NovaMed, Inc. issued a press release announcing its results of
operations for the period ended June 30, 2006. A copy of the press release
is
attached to this Current Report on Form 8-K as Exhibit 99.1.
The
information in this Form 8-K and Exhibit 99.1 attached hereto shall not be
deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, nor shall it be deemed incorporated by reference in any filing under
the
Securities Act of 1933, except as shall be expressly set forth by specific
reference in such filing.
Section
9 - Financial Statements and Exhibits
Item
9.01 Financial Statements and Exhibits
(c) Exhibits
Exhibit
Number Title
---------------- -------------
99.1
Press
release of NovaMed, Inc. dated August 2, 2006
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
NovaMed,
Inc.
|
|
|
|
| Dated:
August 2, 2006 |
By: |
/s/ Thomas
S.
Hall |
| |
Thomas
S. Hall |
| |
President
and
Chief Executive Officer |
EXHIBIT
INDEX
Exhibit
No. Exhibit
99.1 Press
release of NovaMed, Inc. dated August 2, 2006